Transfusion-associated graft-versus-host disease

Vox Sanguinis

Volumn 95, Issue 2, 2008, Pages 85-93

  Dwyre, D M ^a   Holland, P V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Graft versus host; Immunosuppression; Irradiation; Transfusion

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; LEUKOCYTE ANTIGEN; METHOTREXATE; OKT 3; SERINE PROTEINASE INHIBITOR; THYMOCYTE ANTIBODY;

BLOOD TRANSFUSION; BONE MARROW; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SKIN BIOPSY; T LYMPHOCYTE;

ANIMALS; BLOOD; BLOOD TRANSFUSION; BONE MARROW; CHICK EMBRYO; CYTOKINES; DIARRHEA; FEVER; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPETENCE; LIVER DISEASES; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MICE; PANCYTOPENIA; T-LYMPHOCYTE SUBSETS;

EID: 46749141350     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01073.x     Document Type: Review

References (73)

1. Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, Holland PV, Richman C, Paglieroni TG, Wun T : Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplant. Transfusion 2002 42 : 1567 1572
2. Murphy JB : The effect of adult chicken organ graft on the chick embryo. J Exp Med 1916 24 : 1 6
3. Simonsen M : The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Scand 1957 40 : 480 500
4. Billingham RE, Brent L : Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Phil Trans R Soc B Biol Sci 1959 242 : 439 477
5. Terasaki PI : Identification of the type of blood-cell responsible for the graft-versus-host reaction in chicks. J Embryol Exp Morphol 1959 7 : 394 408
6. Billingham RE, Brent L : A simple method for inducing tolerance of skin homografts in mice. Transplant Bull 1957 4 : 67 71
7. Mathe G, Bernard J, Schwarzenberg L : New trials with homologous bone marrow grafts after total irradiation in children with acute leukemia in remission. The problem of secondary syndrome in man. Rev Hematol (Paris) 1960 15 : 115 161
8. Hathaway WE, Githens JH, Blackburn WR, Fulginiti V, Kempe CH : Aplastic anemia, histiocytosis and erythroderma in immunologically deficient children. N Engl J Med 1965 273 : 953 958
9. Naiman JL, Punnett H, Lischner HW, Destiné ML, Arey JB : Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N Engl J Med 1969 281 : 697 701
10. Shimoda T : On postoperative erythroderma (in Japanese). Geka 1955 17 : 487 492
11. Schroeder ML : Transfusion-associated graft-versus-host disease. Br J Haematol 2002 117 : 275 287
12. Aoki Y, Nakamura H, Sakakibara Y : Probable graft-versus-host reaction following massive blood transfusion in an aged patient with postoperative aortic aneurysm: a case report. Nippon Naika Gakkai Zasshi 1984 73 : 1209 1216
13. Ferrara JL, Cooke KR, Pan L, Krenger W : The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996 14 : 473 489
14. Jung U, Foley JE, Erdmann AA, Toda Y, Borenstein T, Mariotti J, Fowler DH : Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. Biol Blood Marrow Transplant 2006 12 : 905 918
15. Shivdasani RA, Haluska FG, Dock NL, Dover JS, Kineke EJ, Anderson KC : Graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med 1993 328 : 766 770
16. Utter GH, Reed WF, Lee TH, Busch MP : Transfusion-associated microchimerism. Vox Sang 2007 93 : 188 195
17. Sazama K, Holland PV : Transfusion-induced graft-versus-host disease in Garratty G (ed.) : Immunobiology of Transfusion Medicine. New York, NY, Marcel Dekker, 1993
18. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED : Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974 6 : 367 371
19. Marra DE, McKee PH, Nghiem P : Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 2004 51 : 543 546
20. Heymer B : Histopathological Manifestations of Acute Gvhd; in Clinical and Diagnostic Pathology of Graft-Versus-Host-Disease. Berlin, Germany, Springer, 2002
21. Sohi I, Jacob S : Transfusion associated GVHD. Indian J Pediatr 2005 72 : 533 535
22. Hahn AB, Baliga P : Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000 6 : 180 184
23. Sakurai M, Moizumi Y, Uchida S, Imai Y, Tabayashi K : Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy. Am J Hematol 1998 58 : 84 86
24. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, Owings JT, Holland PV, Busch MP : High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005 45 : 1280 1290
25. Adams KM, Nelson JL : Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004 291 : 1127 1131
26. Utter GH, Nathens AB, Lee TH, Reed WF, Owings JT, Nester TA, Busch MP : Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Transfusion 2006 46 : 1863 1869
27. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SBD, Vigorito AC, Aranha FJP, de Brito Eid KA, Oliveira GB, Miranda ECM, de Souza CA, Visentainer JEL : IL-2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol 2007 66 : 703 710
28. Jacobsohn DA, Vogelsang GB : Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr Pharm Des 2004 10 : 1195 1205
29. Carey PM, Sacher RA : Transfusion-associated graft versus host disease in Simon TL, Dzik WH, Snyder EL, Stowell CP, Strauss RG (eds) : Rossi's Principles of Transfusion Medicine. Philadelphia, PA, Lippincott, 2002
30. Ohto H, Anderson KC : Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996 10 : 31 43
31. Ohto H, Anderson KC : Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 1996 36 : 117 123
32. Boldt DH, Von Hoff DD, Kuhn JG, Hersh M : Effects on human peripheral lymphocytes of in vivo administration of 9-β-D-arabinofuranosyl-2- fluoroadenine-5′-monophosphate (NSC 312887), a new purine antimetabolite. Cancer Res 1984 44 : 4661 4666
33. Maung ZT, Wood AC, Jackson GH, Turner GE, Appleton AL, Hamilton PJ : Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1994 88 : 649 652
34. Briz M, Cabrera R, Sanjuán I, Forés R, Díez JL, Herrero M, Regidor C, Algora M, Fernández MN : Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1995 91 : 409 411
35. Williamson LM, Wimperis JZ, Wood ME, Woodcock B : Fludarabine treatment and transfusion-associated graft-versus-host disease. Lancet 1996 348 : 472 473
36. Deane M, Gor D, Macmahon ME, Emery V, Griffith PD, Cummins M, Prentice HG : Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment. Br J Haematol 1997 99 : 162 164
37. Leitman SF, Tisdale JF, Bolan CD, Popovsky MA, Klippel JH, Balow JE, Boumpas DT, Illei GG : Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 2003 43 : 1667 1671
38. Chasty RC, Myint H, Oscier DG, Orchard JA, Bussutil DP, Hamon MD, Prentice AG, Copplestone JA : Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA). Leuk Lymphoma 1998, 29 : 391 398
39. Zelig O, Dacosta Y, Oz D, Mamen N : TA-GVHD following fludarabine treatment in a patient with NHL. Abstracts of the Sixth Regional European Congress of the International Society of Blood Transfusion 1999, 128a
40. Davis JC, Tassiulas IO, McInnes IB, Illei GG, Fleisher T, Boumpas DT : Lymphocyte reconstitution after intravenous fludarabine in patients with rheumatoid arthritis (Abstract). Arthritis Rheum 1998 41 : S138
41. Kruskall MS, Lee TH, Assmann SF, Laycock M, Kalish LA, Lederman MM, Busch MP : Survival of transfused donor white blood cells in HIV-infected recipients. Blood 2001 98 : 272 279
42. Ohto H, Yasuda H, Noguchi M, Abe R : Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives. Transfusion 1992 32 : 691 693
43. Agbaht K, Altintas ND, Topeli A, Gokoz O, Ozcebe O : Transfusion- associated graft-versus-host disease in immunocompetent patients: case series and review of the literature. Transfusion 2007 47 : 1405 1411
44. Sola MA, España A, Redondo P, Idoate MA, Fernandez AL, Llorens R, Quintanilla E : Transfusion-associated acute graft-versus-host disease in a heart transplant recipient. Br J Dermatol 1995 132 : 626 630
45. Wisecarver JL, Cattral MS, Langnas AN, Shaw BW, Fox IJ, Heffron TG, Rubocki RJ : Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers. Transplantation 1994 58 : 269 271
46. Triulzi DJ, Nalesnik MA : Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion 2001 41 : 419 426
47. Ryo R, Saigo K, Hashimoto M, Kohsaki M, Yasufuku M, Watanabe N, Okada M, Tadokoro K, Juji T : Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 1999 76 : 241 246
48. Nishimura M, Hidaka N, Akaza T, Tadokoro K, Juji T : Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease. Transfus Med 1998 8 : 209 214
49. Yasukawa M, Shinozaki F, Hato T, Takada K, Ishii Y, Tamai T, Takamatsu H, Shiobara S, Yoshizaki K, Fujita S : Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 1994 86 : 831 836
50. Mori S, Matsushita H, Ozaki K, Tokuhira M, Nakajima H, Kizaki M, Sugiura H, Kikuchi A, Handa M : Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 1995 35 : 431 435
51. Nishimura M : Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease [Letter]. Vox Sang 1998 75 : 306 307
52. Leitman SF, Holland PV : Irradiation of blood products. Indications and guidelines. Transfusion 1985 25 : 293 300
53. Weinmann M, Hoffman W, Rodegerdts E, Bamberg M : Biological effects of ionizing radiation on human blood components ex vivo. J Cancer Res Clin Oncol 2000 126 : 584 588
54. AABB : Standards for Blood Banks and Transfusion Services, 24th edn. Bethesda, MD, AABB, 2006
55. Asai T, Inaba S, Ohto H, Osada K, Suzuki G, Takahashi K, Tadokoro K, Minami M : Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan. Transfus Med 2000 10 : 315 320
56. The Stationery Office : Guidelines for the blood transfusion services in the UK, 7th edn. London, The Stationery Office, 2005
57. Janatpour K, Denning L, Nelson K, Betlach B, MacKenzie M, Holland P : Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells. Vox Sang 2005 89 : 215 219
58. Relevy H., Koshkaryev A, Manny N, Yedgar S, Barshtein G : Blood banking-induced alteration of red blood cell flow properties. Transfusion 2008 48 : 136 148
59. Weiskopf RB, Schnapp S, Rouine-Rapp K, Bostrom A, Toy P : Extracellular potassium concentrations in red blood cell suspensions after irradiation and washing. Transfusion 2005 45 : 1295 1301
60. Sweeney JD : Universal leukoreduction of cellular blood components in 2001? Yes. Am J Clin Pathol 2001 115 : 666 673
61. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE : Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004 103 : 333 339
62. King KE, Shirey RS, Thoman SK, Bensen-Kennedy D, Tanz WS, Ness PM : Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004 44 : 25 29
63. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL : Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004 44 : 16 24
64. Williamson LM, Stainsby D, Jones H, Love E, Chapman CE, Navarrete C, Lucas G, Beatty C, Casbard A, Cohen H : The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 2007 47 : 1455 1467
65. Grass JA, Wafa T, Reames A, Wages D, Corash L, Ferrara JLM, Lin L : Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999 93 : 3140 3147
66. Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R : Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-γ c-/- double knockout mice. Transfusion 2006 46 : 1553 1560
67. Fast LD, DiLeone G, Li J, Goodrich R : Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006 46 : 642 648
68. Grass JA, Hei DJ, Metchette K, Cimino GD, Wiesehahn GP, Corash L, Lin L : Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998 91 : 2180 2188
69. Fast LD, DiLeone G, Edson CM, Purmal A : Inhibition of murine GVHD by PEN110 treatment. Transfusion 2002 42 : 1326 1332
70. Rios JA, Hambleton J, Viele M, Rugg N, Sindermann G, Greenwalt T, Wages D, Cook D, Corash L : Viability of red cells prepared with S-303 pathogen inactivation treatment. Transfusion 2006 46 : 1778 1786
71. Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L : A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 2008 doi
72. Cui Z, Huang Y, Mo Q, Wang X, Qian K : Inactivation of lymphocytes in blood products using riboflavin photochemical treatment with visible light. Photochem Photobiol 2008 doi
73. Brecher M. (ed.) : Technical Manual: AABB, 15th edn. Bethesda, MD, American Association of Blood Banks, 2005